Drug repurposing is no panacea in race to treat COVID-19

Drug repurposing is no quick fix for developing new treatments for disease, including COVID-19, and there are inherent dangers and pitfalls with translating drugs such as chloroquine, hydroxychloroquine, ivermectin and similar compounds to treat COVID-19, say a team of experts.

This post was originally published on this site

Lawyers Lookup - LawyersLookup.ca